Physician profile
Michael S Bauer
NPI 1821136219
$2,851.58
in general payments reported to CMS, 2019-2025
37 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $144 · 2021: $135 · 2022: $375 · 2023: $343 · 2024: $1,278 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,411 · Travel and Lodging: $489 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.08 |
| Travel and Lodging | $488.62 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,092.21 | 2019-2024 | |
| Davol INC. | $261.29 | 2019-2025 | Phasix Mesh, Surgiphor |
| Csl Behring | $118.06 | 2022-2025 | Kcentra, Haegarda |
| Z-Medica, LLC | $115.27 | 2019-2020 | |
| Hologic Sales and Service, LLC | $109.68 | 2023-2024 | Coolseal Generator |
| Integra Lifesciences Corporation | $94.47 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $93.43 | 2019-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Medtronic, INC. | $80.34 | 2022-2025 | Signia, Sonicision, Ligasure |
| Atricure, INC. | $71.00 | 2021-2023 | |
| Acell, INC. | $67.04 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.10 | 2022-2023 | Gattex |
| Histosonics, INC. | $50.15 | 2025 | |
| Merck Sharp & Dohme LLC | $48.46 | 2019-2020 | |
| Enterra Medical, INC. | $46.40 | 2022 | |
| Teleflex LLC | $44.25 | 2022-2024 | Titan Sgs |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $39.55 | 2022 | |
| Organogenesis INC. | $37.93 | 2022-2023 | Puraply |
| Mimedx Group, INC. | $34.40 | 2024-2025 | |
| Ethicon US, LLC | $33.41 | 2020-2023 | Ethicon, Vistaseal |
| Abbvie INC. | $28.04 | 2023 | |
| Tela Bio, INC. | $25.85 | 2024 | Ovitex 2s |
| Solventum Corporation | $24.50 | 2025 | Abthera Advance, 3m Cavilon, V.A.C.Ulta |
| Innovation Technologies INC | $22.38 | 2022 | |
| Allergan, INC. | $22.19 | 2019 | |
| Mallinckrodt Hospital Products INC. | $20.33 | 2020 | |
| Kls-Martin L.P. | $20.18 | 2021 | |
| Innocoll Pharmaceuticals Limited | $20.00 | 2021 | |
| Octapharma USA, INC. | $19.91 | 2025 | Fibryga |
| Mesh Suture INC | $19.87 | 2024 | |
| Polynovo North America LLC | $19.86 | 2025 | Novosorb Btm |
| Eagle Pharmaceuticals, INC. | $19.38 | 2023 | |
| Mallinckrodt Enterprises LLC | $18.19 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.66 | 2025 | |
| Convatec INC. | $16.27 | 2025 | |
| Boston Scientific Corporation | $15.92 | 2024 | Spyglass Discover |
| Covidien LP | $14.82 | 2019 | |
| Kerecis Limited | $11.79 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.